Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.45 AUD Market Closed
Market Cap: 155.2m AUD

Intrinsic Value

The intrinsic value of one ARX stock under the Base Case scenario is 1.2 AUD. Compared to the current market price of 0.45 AUD, Aroa Biosurgery Ltd is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARX Intrinsic Value
1.2 AUD
Undervaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Aroa Biosurgery Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ARX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ARX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Aroa Biosurgery Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Aroa Biosurgery Ltd’s research
View All Researches
Aroa Biosurgery Ltd
ASX:ARX
NZ
Biotechnology
Market Cap
155.2m AUD
IPO
Jul 24, 2020
NZ
Biotechnology
Market Cap
155.2m AUD
IPO
Jul 24, 2020
Price
AU$false
EPS
NZ$false
AI Assistant
AI Assistant
Ask me anything about Aroa Biosurgery Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aroa Biosurgery Ltd

Current Assets 64m
Cash & Short-Term Investments 21.9m
Receivables 29.1m
Other Current Assets 13m
Non-Current Assets 41.7m
PP&E 22.3m
Intangibles 19.3m
Other Non-Current Assets 93k
Efficiency

Free Cash Flow Analysis
Aroa Biosurgery Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aroa Biosurgery Ltd

Revenue
76.4m NZD
Cost of Revenue
-10.2m NZD
Gross Profit
66.1m NZD
Operating Expenses
-76m NZD
Operating Income
-9.9m NZD
Other Expenses
2.3m NZD
Net Income
-7.6m NZD
Fundamental Scores

ARX Profitability Score
Profitability Due Diligence

Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive 1-Year Revenue Growth
35/100
Profitability
Score

Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ARX Solvency Score
Solvency Due Diligence

Aroa Biosurgery Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
86/100
Solvency
Score

Aroa Biosurgery Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARX Price Targets Summary
Aroa Biosurgery Ltd

Wall Street analysts forecast ARX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARX is 0.86 AUD with a low forecast of 0.76 AUD and a high forecast of 0.98 AUD.

Lowest
Price Target
0.76 AUD
68% Upside
Average
Price Target
0.86 AUD
92% Upside
Highest
Price Target
0.98 AUD
117% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aroa Biosurgery Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ARX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARX stock?

The intrinsic value of one ARX stock under the Base Case scenario is 1.2 AUD.

Is ARX stock undervalued or overvalued?

Compared to the current market price of 0.45 AUD, Aroa Biosurgery Ltd is Undervalued by 62%.

Back to Top